Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow.
The Position
As the Head of Analytical Development Pharmaceuticals, you will lead the newly created department Analytical Development Pharmaceuticals aligning its direction with the global Development strategy. You will be responsible for all aspects of Drug Substance and Drug Product characterization, including method development, validation, and stability studies. Your leadership will ensure the department effectively supports global drug development and the seamless transfer to Operations.
APCT1_DE